Innovation Gateway
High quality incubator space in a place purpose-built for collaboration, discovery and growth.
Built for collaboration & pace
Versatile and high tech spaces for team catch ups, board meetings, investor presentations and events.
Hit the ground running with flexible, scalable office and lab space within a collaborative ecosystem.
A dedicated facilities management team, and access to superb shared facilities mean you can focus on your business.
Superfast Wifi, access to your space 24/7 and great transport connections ensure nothing gets in the way of your work.
Innovation Gateway floor plan
Ground Floor
Labs
GF1
561 sq.ft.
GF2
504 sq.ft.
GF3
492 sq.ft.
Offices
Open Office
852 sq.ft.
Office 5
54 sq.ft.
Office 6
120 sq.ft.
First Floor
Labs
FF1
330 sq.ft.
FF2
378 sq.ft.
FF3
372 sq.ft.
FF4
362 sq.ft.
FF5
118 sq.ft.
FF6
221 sq.ft.
Offices
Office 1
117 sq.ft.
Office 2
123 sq.ft.
Office 3
121 sq.ft.
Office 4
180 sq.ft.
Meeting Rooms
Meeting Room 3
See who’s here already
The Innovation Gateway has attracted an energetic mix of life science innovators advancing cancer research, diagnostics and therapeutic technologies. This growing ecosystem is creating a powerful community where ideas are exchanged and collaborations flourish, supported by proximity to leading research and clinical teams.
People & stories
Vesynta – Patient Personalised Dosing
Listen to Dr Alaric Taylor talking about Vesynta at The London Cancer District. Vesynta’s DosoLogic is the prescribing co-pilot that brings model-informed precision dosing (MIPD) to the point of care for safer, patient-specific doses.
ExoNostic – Next-generation liquid biopsy diagnostics
Listen to Dr Meysam Keshavaraz talking about ExoNostic at The London Cancer District. ExoNostic is developing next-generation liquid biopsy diagnostics that enable earlier and more accessible disease detection. Their platform applies holistic molecular analysis to small biological samples, generating detailed diagnostic insights that support early cancer detection, treatment monitoring and wider biomarker discovery.
Kindling Bio – Pioneering child-first gene therapy platform
Listen to Jeff Drew talking about Kindling Bio at The London Cancer District. Kindling Bio is a London-based biotechnology start-up treating one scalable gene therapy to flag multiple childhood tumors for immune destruction.
Take a virtual tour
Contact us for a visit
If you are looking for flexible laboratory or office space within a leading life sciences ecosystem, we would be pleased to discuss current availability and your requirements.
"*" indicates required fields
Our partners
